Skip to main content

Closed

RXRX: Recursion Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

5thpctl

Volume

0.74×avg

Market Cap

1.57BUSD

P/E Ratio

-2.5TTM

Div Yield

-ann

Recursion Pharmaceuticals, Inc.

RXRXNASDAQ Global Select·USD·Closed

Recursion Pharmaceuticals, Inc.

RXRXNASDAQ·USD·Closed

$3.00

−1.32%

$3.00

−$0.04 (1.32%)

52W Range

5thpctl

Volume

0.74×avg

Mkt Cap

1.57BUSD

P/E

-2.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings